Oncotelic Therapeutics, Inc. Paid-in-Kind Interest
Oncotelic Therapeutics, Inc. (OTLC) reported Paid-in-Kind Interest of $54.74 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-04-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2022-04-15
- Oncotelic Therapeutics, Inc. paid-in-kind interest for fiscal 2020 was $54.74K.
| Period end | Paid-in-Kind Interest 12 month |
|---|---|
| 2020-12-31 | $54.74K 10-K · filed 2022-04-15 |